Matthew_Speers

UCB’s Speers to lead European Medicines Group

July 19, 2010
Sales and Marketing European Medicines Group, UCB, appointment, sales and marketing

UCB Pharma’s managing director Matthew Speers has been elected chair of the European Medicines Group, taking over from Nigel Brooksby …

NICE reaffirms positive opinion on Multaq

July 19, 2010
Sales and Marketing Multaq, NICE, antiarrhythmic, dronedarone

In its final draft guidance, UK cost-effectiveness body NICE has reaffirmed its previous positive opinion to recommend the limited use …

GSK takes £1.58bn hit from legal disputes

July 16, 2010
Sales and Marketing Avandia, GlaxoSmithKline, Paxcil, Seroxat

GlaxoSmithKline is set to pay £1.58 billion to settle three long-standing legal disputes, including litigation costs for its troubled diabetes …

Lonza wins two biologic contracts

July 16, 2010
Manufacturing and Production Elusys, Human Genome Sciences, Lonza

Swiss fine chemicals firm Lonza has secured two new contracts for its contract manufacturing division for monoclonal antibodies to treat …

UK pharma needs online pharmacovigilance guidance, says Digital Pioneer

July 16, 2010
Medical Communications Code of Practice, Sublime Digital, digital pharma

Pharma companies need more help from UK authorities on the issue of online pharmacovigilance, according to the winner of the …

Eisai collaborates on psychiatric disorder research

July 16, 2010
Research and Development Aestus Thereapeutics, Eisai

Eisai is to work with US-based translational medicine company Aestus Therapeutics to develop novel treatments for psychiatric disorders. The companies’ …

Changing business models top pharma concerns

July 16, 2010
Sales and Marketing Cegedim, industry, survey

The changing face of pharma business models is the main thing keeping US executives awake at night, according to a …

What might the NHS white paper mean for Pharma commercial models?

July 16, 2010
Sales and Marketing Kinapse, NHS, White paper, commercial model, life sciences, pharma

Earlier this year we published a white paper on the new commercial realities and their implications for Life Sciences companies.

Promotions at ScopeMedical

July 16, 2010
Medical Communications ScopeMedical, appointment, medical communications

Kent, UK-based medical communications agency ScopeMedical has promoted a number of its team.They are: Sophie Smith (who moves to account …

Olivier Bohuon joins Pierre Fabre

July 16, 2010
Sales and Marketing Abbott, Pierre Fabre, appointment, sales and marketing

Olivier Bohuon is to replace Jean-Pierre Garnier as the head of French pharma company Pierre Fabre from September. Bohuon is …

Best GPs will outperform PCTs, says PCT leader

July 15, 2010
Sales and Marketing NHS, commissioning

The leader of the PCT managers’ organisation David Stout and Mark Britnell, the architect of the former Labour government’s commissioning …

Semi-synthetic shortcut could boost supply of antimalarial

July 15, 2010
Manufacturing and Production malaria

US researchers are pushing forward with the development of a cheaper, semi-synthetic version of artemisinin, the basis of the most …

New products spur Novartis growth

July 15, 2010
Sales and Marketing Novartis, Tasigna

Novartis has posted strong results for the second quarter of the year. The Swiss pharma company posted an 11% rise …

Pfizer form liver cancer research partnership in Korea

July 15, 2010
Research and Development

 Pfizer has formed a research partnership with Samsung Medical Centre in Seoul for the analysis of Korean liver cancer patients …

john-beighton

Goldshield appoints John Beighton

July 15, 2010
Sales and Marketing Goldshield, appointment, sales and marketing

UK generics company Goldshield has appointed John Beighton as chief executive. Beighton was formerly UK managing director of Teva, and …

Medea appoints NHS advisor

July 15, 2010
Medical Communications Medea, appointment, medical communications

PR agency Medea Communications has engaged the former chair of a major hospital drugs and therapeutics committee to act as …

John-Castellani

John Castellani to lead PhRMA

July 15, 2010
Sales and Marketing PhRMA, appointment, sales and marketing

US pharma association PhRMA has appointed John Castellani president and chief executive, with effect from September. He will join the …

CME Spotlight: Performance improvement and collaboration

July 15, 2010
Medical Communications CME, CME Spotlight, Eugene Pozniak

In the 1990s we were informed by TV commercials with slick voice-overs and a backdrop of huge traffic jams, that …

Blog footer

Digital Pharma: Social media an ‘enigma’ for pharma

July 15, 2010
Medical Communications Cegedim, Digital Pharma blog, digital pharma, industry, social media

The vast majority of pharma companies now use social media in one form or another, but it is unclear how …

Avandia

GSK accused of Avandia cover-up

July 14, 2010
Sales and Marketing Avandia, GlaxoSmithKline, diabetes

The ongoing battle over GlaxoSmithKline’s diabetes drug Avandia has taken another turn with US senators accusing the company of a …

The Gateway to Local Adoption Series

Latest content